BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1901455)

  • 1. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.
    Murphy GF; Whitaker D; Sprent J; Korngold R
    Am J Pathol; 1991 Apr; 138(4):983-90. PubMed ID: 1901455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic folliculitis in GvHD. Evidence of follicular stem cell injury and recovery.
    Murphy GF; Lavker RM; Whitaker D; Korngold R
    J Cutan Pathol; 1991 Oct; 18(5):309-14. PubMed ID: 1761782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M; Wettstein PJ; Korngold R
    Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC; Friedman TM; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease.
    Murphy GF; Sueki H; Teuscher C; Whitaker D; Korngold R
    J Invest Dermatol; 1994 Apr; 102(4):451-61. PubMed ID: 7908682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation.
    Miconnet I; de La Selle V; Bruley-Rosset M
    Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.
    Korngold R; Sprent J
    J Exp Med; 1987 Jun; 165(6):1552-64. PubMed ID: 3108446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
    J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies.
    Cobbold SP; Martin G; Waldmann H
    Eur J Immunol; 1990 Dec; 20(12):2747-55. PubMed ID: 1980112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.
    Guillén FJ; Ferrara J; Hancock WW; Messadi D; Fonferko E; Burakoff SJ; Murphy GF
    Lab Invest; 1986 Jul; 55(1):35-42. PubMed ID: 3523039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
    Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
    Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation.
    Korngold R; Leighton C; Manser T
    Transplantation; 1994 Aug; 58(3):278-87. PubMed ID: 7914387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity.
    Sykes M; Abraham VS; Harty MW; Pearson DA
    J Immunol; 1993 Jan; 150(1):197-205. PubMed ID: 8093257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.